February 8, 2012

The Food and Drug Administration has approved a head lice treatment made by Sanofi, the drug maker said.

February 8, 2012

Takeda Pharmaceutical has launched a drug for treating high blood pressure in adults, the company said.

February 8, 2012

Specialty pharmacy provider The Apothecary Shops has inked a deal with Pfizer to distribute a new drug for treating kidney cancer.

February 7, 2012

The Food and Drug Administration has approved a drug made by Shire for attention deficit hyperactivity disorder, the company said Tuesday.

February 7, 2012

A drug under development by Merck "significantly" reduced the risk of heart attack, stroke and cardiovascular death in patients, according to clinical trial results announced Tuesday.

February 7, 2012

Cardinal Health was granted a temporary restraining order Friday against the Drug Enforcement Administration's suspension order of its Lakeland, Fla., distribution center.

February 7, 2012

Two members of Congress are looking for co-sponsors for a bill that would strengthen the medication therapy management benefit in the Medicare prescription drug program.

February 7, 2012

Apparently, there’s life after Express Scripts.

February 6, 2012

Mylan has completed its acquisition of two skin drugs from Valeant Pharmaceuticals, the generic drug maker said Monday.

February 6, 2012

In honor of American Heart Month, Sam's Club announced it will be hosting free heart health screenings on Feb. 11 at all locations with a pharmacy.

February 6, 2012

Pregnant women with diabetes are almost four times more likely to have a baby with a birth defect than women without the condition, and the likelihood is linked to the mother's glucose level, according to a new study released by Newcastle University Monday.

February 3, 2012

The impact of the failed Express Scripts negotiations on Walgreens' sales has been significant to date, as evidenced by Walgreens' January sales release issued Friday.

February 3, 2012

Max-Wellness is preparing to introduce its “Wellness-in-a-Box” concept — an automated dispensing device located in a variety of unique venues featuring health-and-wellness products that customers can purchase at any time using a debit or credit card. The concept is slated to make its debut in March, the company stated.

February 3, 2012

For all the fears about the patent cliff, at least one disease state seems to be on the up-and-up in terms of new drug development and new products.

February 3, 2012

The Department of Defense investigation's of a sports supplement ingredient — associated with the death of two soldiers — has been making headlines in the past week as the U.S. Military's independent paper Stars & Stripes ran an update of the news on Jan. 29 and the New York Times picked up on the story Feb. 2.

February 3, 2012

The regulatory waiting period standing between Bristol-Myers Squibb and its acquisition of drug maker Inhibitex has expired, giving Bristol the green light to buy the company.

February 3, 2012

A study on Bausch + Lomb's Biotrue multipurpose contact lens solution published in the January edition of the journal Eye & Contact Lens: Science & Clinical Practice found that the solution can help improve eye health.

February 3, 2012

Endocrinologists would prescribe a newly approved weekly treatment for Type 2 diabetes to one-fifth of their patients, a new survey showed.

February 3, 2012

Teva Pharmaceuticals has launched a generic version of a psychiatric drug, the company said Friday.

February 3, 2012

Walgreens is helping to redefine what it means to be a successful retail pharmacy operator. The proof is in this new direction that Walgreens is taking — approaching employers and payers with a comprehensive, cost-lowering strategy across that company's entire health spend, not just their prescription spend.

February 2, 2012

The Food and Drug Administration has approved a drug made by Merck for Type 2 diabetes, the drug maker said Thursday.

February 2, 2012

The Food and Drug Administration has given tentative approval to a generic cholesterol drug made by Mylan, the drug maker said Thursday.

February 2, 2012

More than 50 drugs are under development for treating a respiratory disease that is the third-leading cause of death in the United States.

February 1, 2012

The Food and Drug Administration has approved a drug made by Novartis that is designed to prevent tumors in the gastrointestinal tract from recurring after surgical removal, the agency said.